Image Credits: All patient images are courtesy of Desiree Ratner, MD Did you enjoy this post
Open dialogue enables better risk assessment and tailored advice, ultimately improving patient outcomes and safety
The weight loss benefits of either drug can depend on various factors, including overall medical history and the response to the medication
The SELECT trial (Lincoff et al., N Engl J Med, 2023) demonstrated a 20% reduction in major adverse cardiovascular events with semaglutide 2.4 mg in overweight/obese patients with established cardiovascular disease
For patients with moderate constipation, osmotic laxatives such as macrogol are particularly effective in softening stools and increasing bowel movement frequency
The hair loss is generally temporary, with regrowth typically beginning within 3-6 months once the body adjusts to the new metabolic state